It sis recommended in treating MDR & UTI
to treat upper & Lower respiratory Tract infection
Soft tissue infection
gynecological infection
complete coverage against streptococcus pneumoniae
Oral B Lactam antibiotic 5-10 MG/KG every 12 hourly oral administration
Corofenam comes in two variations to offer targeted and enhanced antibiotic therapy. The Faropenem Sodium 200mg version is a broad-spectrum β-lactam antibiotic effective against Gram-positive, Gram-negative, aerobic, and anaerobic bacteria, making it ideal for general infections. The Faropenem Sodium 200mg + Potassium Clavulanate 125mg combination enhances efficacy by inhibiting β-lactamase enzymes, making it more effective against drug-resistant bacteria in severe or complicated infections like MDR-UTI, respiratory tract infections, and soft tissue infections. This dual approach ensures superior efficacy, higher safety, and better clinical outcomes, making Corofenam the preferred choice for physicians treating a wide range of infections.
Corofenam/CV contains Faropenem, a β-lactam antibiotic with broad-spectrum activity against Gram-positive, Gram-negative, aerobic, and anaerobic bacteria. It is highly effective in treating infections resistant to conventional antibiotics, including Multi-Drug Resistant (MDR) Urinary Tract Infections (UTIs), respiratory tract infections, and soft tissue infections. The addition of Potassium Clavulanate in Corofenam/CV further enhances its efficacy by inhibiting β-lactamase-producing bacteria, ensuring complete bacterial eradication.
Unlike traditional carbapenems, Corofenam exhibits a better safety profile with minimal gastrointestinal side effects. Its oral administration ensures better patient tolerance, reducing the risk of diarrhea, nausea, or abdominal discomfort. The precise formulation allows for better absorption, ensuring higher drug efficacy with reduced systemic toxicity, making it a safer and more effective choice for a wide range of infections.
Q
A
Corofenam is a broad-spectrum β-lactam antibiotic containing Faropenem, which effectively treats bacterial infections by inhibiting bacterial cell wall synthesis. It is highly effective against Gram-positive, Gram-negative, aerobic, and anaerobic bacteria, making it a preferred choice for respiratory, urinary tract, and soft tissue infections.
Q
A
Corofenam offers higher potency at lower doses (5-10 mg/kg) compared to other carbapenems like Meropenem (12-24 mg/kg). It has a superior safety profile, minimal gastrointestinal side effects, and oral administration, making it a convenient alternative to injectable antibiotics for multi-drug resistant infections.
Q
A
Corofenam is recommended for treating MDR urinary tract infections, upper & lower respiratory tract infections, gynecological infections, and soft tissue infections. It provides complete coverage against Streptococcus pneumoniae and β-lactamase-producing bacteria, making it effective in both acute and chronic bacterial infections.